Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGUS Fro…

Insights from 2023 ASH Annual Meeting

R. Banerjee

Should Patients With High-Risk SMM Be Treated Outside a Clinical Tri…

Scripps Health

M. Gertz

Why We Should Not Treat SMM

PleXus Communications

B. Derman

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Indy Hematology Review

M. Gertz

Emerging and Current Treatment of MM: What Should We Know and What S…

Indy Hematology Review

K. Anderson

Myeloma in 2023: So Many Drugs, Yet So Few Cures

Yale Cancer Center

A. Chari

SOHO Italy 2023: Multiple Myeloma Cured in 2030 - What Are the Next …

5th SOHO Italy Annual Conference

K. Anderson

Updates in the Management of SMM/MGUS and the Prevention of Progress…

Dana-Farber Cancer Institute

Y. Liu

Oncologists' Guidance on Treating Smoldering Myeloma: Panel Discussi…

GRACE

A. Goodman, A. Taneja, T. Phillips

Management of Smoldering Myeloma

XV Eurasian Hematology-Oncology Congress - EHOC 2024

C. Cerchione

ASH 2023 Insights: "iStopMM Study - Risk Factors of Smoldering Multi…

Insights from 2023 ASH Annual Meeting

S. Thorsteinsdottir

SOHO 2023 DEBATE: Smoldering MM - Time to Watch and Wait

SOHO 2023 Eleventh Annual Meeting

A. Dispenzieri

Smoldering Myeloma: If and When to Treat

Victor Jimenez Zepeda

SOHO Italy 2023: Is It Time for a Biomarkers-Driven Approach in Smol…

5th SOHO Italy Annual Conference

I. Ghobrial

SOHO 2022: Next Questions for MM in the Coming 5-10 Years

SOHO 2022 Tenth Annual Meeting

T. Martin

Myeloma 2022: Challenges and Path Forward

UChicago Medicine

A. Jakubowiak

ASH 2023 Insights: "Daratumumab, Bortezomib, Lenalidomide, and Dexam…

Insights from 2023 ASH Annual Meeting

O. Nadeem

Myeloma Rounds: Asymptomatic Patient With High-Risk SMM

PleXus Communications

N. Antao, P. Hagen